Tumour dormancy: findings and hypotheses from clinical research on breast cancer

By demicheli R.  

Seminars in Cancer Biology, Vol. 11, Iss. 4, 2001-08 ,pp. : 297-306

Academic Press

Access to resources Recommend Favorite

Circulating tumour cells in breast cancer

By Ring A.   Smith I.E.   Dowsett M.  

Lancet Oncology, Vol. 5, Iss. 2, 2004-02 ,pp. : 79-88

Elsevier

Access to resources Recommend Favorite

Tumour marker CA15-3: possible uses in the routine management of breast cancer

By Tomlinson I.P.M.   Whyman A.   Barrett J.A.   Kremer J.K.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 899-902

Elsevier

Access to resources Recommend Favorite

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 790-797

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical significance of sentinel lymph node isolated tumour cells in breast cancer

By Patani Neill  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 325-334

Springer Publishing Company

Access to resources Recommend Favorite